Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Princess Margaret Hospital is joining Merck's global oncology research network, a group of leading international cancer research institutions working together to develop new cancer drugs faster for patients.
The $17.3-million partnership over five years was announced April 15 at PMH by Ontario's Minister for Research and Innovation, John Milloy, and Merck Canada President Carlos Dourado. The Ontario government investment is $2.6 million through its Biopharmaceutical Investment Program.
Leading the partnership for PMH are Drs. Ben Neel, Director of the Ontario Cancer Institute and the Campbell Family Cancer Research Institute, and Dr. Malcolm Moore, who heads the Department of Medical Oncology and Hematology and the Robert and Maggie Bras and Family New Drug Development Program.
"PMH and Merck are aligned with a passion to find new cancer drugs," said Dr. Moore. "This is exciting and important work to give patients early access to new compounds. We are also asking the question why drugs work in some people, but not others."
Dr. Chris Paige, Vice-President, Research at UHN, said: "The PMH Cancer Program at UHN is pleased to be a partner in this network as it will enable our patients to benefit from early access to innovative treatments."